Gary Chan

3.2k citations

58 papers · 2.4k indexed · 2 hit papers · h-index 22

Impact in

Dermatology top 0.5%
- Dermatology and Skin Diseases
Immunology and Allergy top 1%
- Allergic Rhinitis and Sensitization

Papers in ⓘ

Dermatology 20
- Dermatology and Skin Diseases 19
Immunology and Allergy 10
- Allergic Rhinitis and Sensitization 10

Co-authors: Nervin Lawendy (19 shared papers)Chudy I. Nduaka (10 shared papers)Chinyu Su (14 shared papers)Sriram Krishnaswami (6 shared papers)Bruce E. Sands (7 shared papers)Julián Panés (9 shared papers)Michele Moscariello (6 shared papers)Hernán Valdez (10 shared papers)
Journals: Journal of Crohn s and Colitis (6 papers)The American Journal of Gastroenterology (5 papers)Inflammatory Bowel Diseases (4 papers)Journal of the European Academy of Dermatology and Venereology (3 papers)American Journal of Transplantation (3 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Gary Chan

56 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis 2020 · 289 citations

Peers

Countries citing papers authored by Gary Chan

Since Specialization

Citations

This map shows the geographic impact of Gary Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Chan more than expected).

Fields of papers citing papers by Gary Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Chan. The network helps show where Gary Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Chan Line = papers co-authored together Gary Chan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials Gut ·Julián Panés, William J. Sandborn, Stefan Schreiber, Bruce E. Sands, Séverine Vermeire, Geert D’Haens, Remo Panaccione, Peter Higgins, Jean‐Frédéric Colombel, Brian G. Feagan, Gary Chan, Michele Moscariello, Wenjin Wang, Wojciech Niezychowski, Amy Marren, Paul J. Healey, Eric Maller Hit paper breakdown →	2017	296
2	Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis JAMA Dermatology ·Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Melinda Gooderham, Gary Chan, Claire Feeney, Pinaki Biswas, Hernán Valdez, Marco DiBonaventura, Chudy I. Nduaka, Ricardo Rojo Hit paper breakdown →	2020	289
3	The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans Drug Metabolism and Disposition ·Martin E. Dowty, Jinyan Lin, Tim F. Ryder, Weiwei Wang, Gregory S. Walker, Alfin D. N. Vaz, Gary Chan, Sriram Krishnaswami, Chandra Prakash	2014	212
4	Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials Clinical Gastroenterology and Hepatology ·William J. Sandborn, Julián Panés, Geert D’Haens, Bruce E. Sands, Chinyu Su, Michele Moscariello, Thomas V. Jones, Ron Pedersen, Gary S. Friedman, Nervin Lawendy, Gary Chan	2018	193
5	Therapeutic targeting of Janus kinases Immunological Reviews ·Marko Pesu, Arian Laurence, Nandini Kishore, Samuel H. Zwillich, Gary Chan, John J. O’Shea	2008	173
6	Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib Inflammatory Bowel Diseases ·Kevin Winthrop, Gil Melmed, Séverine Vermeire, Millie D. Long, Gary Chan, Ronald Pedersen, Nervin Lawendy, Andrew Thorpe, Chudy I. Nduaka, Chinyu Su	2018	167
7	Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis JAMA Dermatology ·Lawrence F. Eichenfield, Carsten Flohr, Robert Sidbury, Elaine C. Siegfried, Zsuzsanna Szalai, Ryszard Galus, Zhirong Yao, Hidetoshi Takahashi, S. Barbarot, Claire Feeney, Fan Zhang, Marco DiBonaventura, Ricardo Rojo, Hernán Valdez, Gary Chan	2021	105
8	Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis Clinical Gastroenterology and Hepatology ·Bruce E. Sands, Pam R. Taub, Alessandro Armuzzi, Gary S. Friedman, Michele Moscariello, Nervin Lawendy, Ronald Pedersen, Gary Chan, Chudy I. Nduaka, Daniel Quirk, Leonardo Salese, Chinyu Su, Brian G. Feagan	2019	80
9	Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open Alimentary Pharmacology & Therapeutics ·Bruce E. Sands, Alessandro Armuzzi, John K. Marshall, James O. Lindsay, William J. Sandborn, Silvio Danese, Julián Panés, Brian Bressler, Jean‐Frédéric Colombel, Nervin Lawendy, Eric S. Maller, Haiying Zhang, Gary Chan, Leonardo Salese, Konstantinos Tsilkos, Amy Marren, Chinyu Su	2019	65
10	Phase 1 Dose-Escalation Study of CP-690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics American Journal of Transplantation ·Eveline van Gurp, Willem Weimar, Robert S. Gaston, Daniel C. Brennan, Robert Mendez, J D Pirsch, Suzanne K. Swan, Mark D. Pescovitz, G. Ni, C. Wang, S. Krishnaswami, Vincent Chow, Gary Chan	2008	59
11	The Jak Inhibitor CP-690,550 Preserves the Function of CD4+CD25brightFoxP3+ Regulatory T Cells and Inhibits Effector T Cells American Journal of Transplantation ·Varsha D. K. D. Sewgobind, Monique E. Quaedackers, Luc J. W. van der Laan, Rens Kraaijeveld, Sander S. Korevaar, Gary Chan, W. Weimar, Carla C. Baan	2010	57
12	Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND) Journal of the American Academy of Dermatology ·Vivian Y. Shi, Tina Bhutani, Luz Fonacier, Mette Deleuran, Stephen Shumack, Hernán Valdez, Fan Zhang, Gary Chan, Michael C. Cameron, Natalie Yin	2022	54
13	Multi-domains lifestyle interventions reduces depressive symptoms among frail and pre-frail older persons: Randomized controlled trial The journal of nutrition health & aging ·Tze Pin Ng, Ma Shwe Zin Nyunt, Lei Feng, Mathew Niti, Boon Yeow Tan, Gary Chan, Sue Anne Khoo, See-Wing Chan, Philip Yap, Keng Bee Yap	2016	48
14	The Effect of the JAK Inhibitor CP-690,550 on Peripheral Immune Parameters in Stable Kidney Allograft Patients Transplantation ·Evelien A. F. J. van Gurp, Wenda Schoordijk-Verschoor, Mariska Klepper, Sander S. Korevaar, Gary Chan, Willem Weimar, Carla C. Baan	2009	47
15	Evaluation of the Effect of Tofacitinib Exposure on Outcomes in Kidney Transplant Patients American Journal of Transplantation ·Flavio Vincenti, (unknown), Stéphan Busque, Philip J. O’Connell, Graeme R. Russ, Klemens Budde, Atsushi Yoshida, Michael A. Tortorici, M. Lamba, Nervin Lawendy, W. Wang, Gary Chan	2015	45
16	Pharmacokinetics of tofacitinib, a janus kinase inhibitor, in patients with impaired renal function and end‐stage renal disease The Journal of Clinical Pharmacology ·Sriram Krishnaswami, Vincent Chow, M. Boy, Cunshan Wang, Gary Chan	2013	44
17	Evaluation of the effect of fluconazole and ketoconazole on the pharmacokinetics of tofacitinib in healthy adult subjects Clinical Pharmacology in Drug Development ·Pankaj Gupta, Vincent Chow, Ronnie Wang, Irina V Kaplan, Gary Chan, Christine Alvey, Grace Ni, Marie‐Noella Ndongo, Robert R. LaBadie, Sriram Krishnaswami	2013	41
18	Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteers Clinical Pharmacology in Drug Development ·Sriram Krishnaswami, M. Boy, Vincent Chow, Gary Chan	2014	35
19	Long‐term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open‐label, 48‐week extension study Alimentary Pharmacology & Therapeutics ·Julián Panés, Geert D’Haens, Peter Higgins, Linda Mele, Michele Moscariello, Gary Chan, Wenjin Wang, Wojciech Niezychowski, Chinyu Su, Eric S. Maller	2019	34
20	Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme Journal of Crohn s and Colitis ·Kevin Winthrop, Edward V. Loftus, Daniel C. Baumgart, Walter Reinisch, Chudy I. Nduaka, Nervin Lawendy, Gary Chan, Rajiv Mundayat, Gary S. Friedman, Leonardo Salese, Andrew Thorpe, Chinyu Su	2020	32

About Gary Chan

Gary Chan is a scholar working on Dermatology, Immunology and Allergy, Transplantation, Pharmacology and Immunology, having authored 58 papers that have together received 2.4k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (19 papers), Inflammatory Bowel Disease (17 papers), Asthma and respiratory diseases (11 papers), Allergic Rhinitis and Sensitization (10 papers), Microscopic Colitis (9 papers), Pharmacological Effects of Natural Compounds (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Diagnosis and treatment of tuberculosis (6 papers). The work is most often cited by research in Dermatology (564 citations), Immunology and Allergy (371 citations), Rheumatology (681 citations), Genetics (870 citations) and Immunology (595 citations). Gary Chan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Nervin Lawendy, Chudy I. Nduaka, Chinyu Su, Sriram Krishnaswami, Bruce E. Sands, Julián Panés, Michele Moscariello, Hernán Valdez, Marco DiBonaventura and Geert D’Haens. Their work appears in journals such as Journal of Crohn s and Colitis, The American Journal of Gastroenterology, Inflammatory Bowel Diseases, Journal of the European Academy of Dermatology and Venereology and American Journal of Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact